These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8955058)
1. The glycosylated gag protein of MuLV is a determinant of neuroinvasiveness: analysis of second site revertants of a mutant MuLV lacking expression of this protein. Portis JL; Fujisawa R; Mcatee FJ Virology; 1996 Dec; 226(2):384-92. PubMed ID: 8955058 [TBL] [Abstract][Full Text] [Related]
2. Identification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus. Portis JL; Spangrude GJ; McAtee FJ J Virol; 1994 Jun; 68(6):3879-87. PubMed ID: 8189525 [TBL] [Abstract][Full Text] [Related]
3. Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China. Bundy LM; Ru M; Zheng BF; Cheng L; Pattengale PK; Portis JL; Fan H Virology; 1995 Oct; 212(2):367-82. PubMed ID: 7571406 [TBL] [Abstract][Full Text] [Related]
4. Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release. Low A; Datta S; Kuznetsov Y; Jahid S; Kothari N; McPherson A; Fan H J Virol; 2007 Apr; 81(8):3685-92. PubMed ID: 17267509 [TBL] [Abstract][Full Text] [Related]
5. A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. Corbin A; Prats AC; Darlix JL; Sitbon M J Virol; 1994 Jun; 68(6):3857-67. PubMed ID: 8189523 [TBL] [Abstract][Full Text] [Related]
7. Unique sequence and lesional tropism of a new variant of neuropathogenic friend murine leukemia virus. Takase-Yoden S; Watanabe R Virology; 1997 Jul; 233(2):411-22. PubMed ID: 9217064 [TBL] [Abstract][Full Text] [Related]
8. The neuroinvasiveness of a murine retrovirus is influenced by a dileucine-containing sequence in the cytoplasmic tail of glycosylated Gag. Fujisawa R; McAtee FJ; Wehrly K; Portis JL J Virol; 1998 Jul; 72(7):5619-25. PubMed ID: 9621020 [TBL] [Abstract][Full Text] [Related]
9. Mapping of a neurovirulence determinant within the envelope protein of a polytropic murine retrovirus: induction of central nervous system disease by low levels of virus. Poulsen DJ; Robertson SJ; Favara CA; Portis JL; Chesebro BW Virology; 1998 Sep; 248(2):199-207. PubMed ID: 9721229 [TBL] [Abstract][Full Text] [Related]
10. Identification of the regions of Fv1 necessary for murine leukemia virus restriction. Bishop KN; Bock M; Towers G; Stoye JP J Virol; 2001 Jun; 75(11):5182-8. PubMed ID: 11333899 [TBL] [Abstract][Full Text] [Related]
11. Increased neurovirulence of polytropic mouse retroviruses delivered by inoculation of brain with infected neural stem cells. Poulsen DJ; Favara C; Snyder EY; Portis J; Chesebro B Virology; 1999 Oct; 263(1):23-9. PubMed ID: 10544079 [TBL] [Abstract][Full Text] [Related]
12. Ubiquitination of HIV-1 and MuLV Gag. Ott DE; Coren LV; Chertova EN; Gagliardi TD; Schubert U Virology; 2000 Dec; 278(1):111-21. PubMed ID: 11112487 [TBL] [Abstract][Full Text] [Related]
13. The cellular protein La functions in enhancement of virus release through lipid rafts facilitated by murine leukemia virus glycosylated Gag. Nitta T; Tam R; Kim JW; Fan H mBio; 2011; 2(1):e00341-10. PubMed ID: 21343359 [TBL] [Abstract][Full Text] [Related]
14. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice. Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339 [TBL] [Abstract][Full Text] [Related]
15. Second-site mutations encoding residues 34 and 78 of the major capsid protein (VP5) of herpes simplex virus type 1 are important for overcoming a blocked maturation cleavage site of the capsid scaffold proteins. Warner SC; Desai P; Person S Virology; 2000 Dec; 278(1):217-26. PubMed ID: 11112496 [TBL] [Abstract][Full Text] [Related]
16. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo. Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422 [TBL] [Abstract][Full Text] [Related]
17. Molecular and pathogenic characterization of the RFB osteoma virus: lack of oncogene and induction of osteoma, osteopetrosis, and lymphoma. Gimbel W; Schmidt J; Brack-Werner R; Luz A; Strauss PG; Erfle V; Werner T Virology; 1996 Oct; 224(2):533-8. PubMed ID: 8874513 [TBL] [Abstract][Full Text] [Related]
18. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice. Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051 [TBL] [Abstract][Full Text] [Related]
19. Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses. Crabtree MB; Kinney RM; Miller BR Arch Virol; 2005 Apr; 150(4):771-86. PubMed ID: 15592895 [TBL] [Abstract][Full Text] [Related]
20. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity. Sugahara D; Tsuji-Kawahara S; Miyazawa M J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]